16/03/2018
*Overview Of Medtronic Covidien INVOS*
(Cerebral/Somatic Oximetry)
The Clinical Standard in Regional Oximetry
The INVOS™ system is the only cerebral/somatic oximetry system with FDA cleared improved outcome claims.
The INVOS™ system provides real-time monitoring of changes in regional oxygen saturation (rSO2) of blood in the brain or other body tissues beneath the sensor for effective oxygen monitoring in adults, children, infants and neonates.
This unique system allows clinicians to measure site-specific oxygen levels rather than requiring them to infer the data from systemic, whole body measures such as blood pressure and pulse oximetry. Available in two or four data channels, clinicians can conveniently monitor multiple brain and body areas.
*Protecting Infants and Neonates in your care*
• Only device to provide noninvasive, simultaneous cerebral/somatic oximetry
• Reflects venous reserve; the surplus of O2 remaining after tissues have taken what they need
• Detects site-specific changes in blood oxygenation
• Often provides earlier warning than traditional measures such as MAP, SpO2, ABGs and lactates1-3
• Helps clinicians detect and correct oxygenation issues such as those associated with:
- Low cardiac output4
- Shock5 and seizures6
- Renal failure7
- Neurologic damage8-9
• Transforms subjective, intangible factors into concrete, actionable data
• Regional, not systemic
• Noninvasive, real-time and continuous
• Helps determine need for and effectsof interventions
